Pyxis Oncology

Pyxis Oncology is a biotechnology company dedicated to developing novel treatments for patients with difficult-to-treat cancers. Their focus is on advancing a differentiated portfolio of clinical assets, including antibody-drug conjugates (ADCs) and immunotherapy candidates. Pyxis Oncology's mission is to improve and extend the lives of cancer patients and their families through disruptive approaches to cancer treatment.

They employ a platform-based approach, leveraging their proprietary FACT and APXiMAB technologies. The FACT platform enables the development of next-generation ADCs with improved stability, potency, and tumor permeability, while APXiMAB facilitates the discovery of diverse antibodies with high affinity, specificity, and stability for use in ADCs and immunotherapies. Their pipeline of clinical assets targets both tumor cells directly and the immune system, aiming to overcome immune suppression and enhance the effectiveness of treatment.

Pyxis Oncology offers a hybrid work model that prioritizes talent over location. Many roles allow for remote work, while headquarters-based positions offer central office and lab space for both in-person collaboration and remote connection. Regular "Home Weeks" bring all employees together at headquarters for face-to-face engagement. The company also provides unlimited vacation time and utilizes advanced technology to facilitate seamless communication and global collaboration with partners.

Pyxis Oncology offers employees a competitive benefits package, including unlimited vacation time, a hybrid work model, and the opportunity to work remotely for many roles. The company also provides central office and lab space in Boston for in-person collaboration and connection, and hosts regular Home Weeks where all employees gather at headquarters for face-to-face engagement and community building. Pyxis leverages technology for seamless communication and global collaboration, prioritizing sustainable work-life balance.

Pyxis Oncology is a biotechnology company dedicated to improving the lives of cancer patients by developing innovative and differentiated biologics that target tumor cells and overcome immune suppression. Their mission is to liberate science to cure patients with cancer, and they believe that antibody-drug conjugates (ADCs) and immunotherapies offer unique potential to address difficult-to-treat cancers, leading to improved patient outcomes.

Pyxis Oncology promotes a culture of collaboration, innovation, and patient-centricity. They value diversity, risk-taking, and a commitment to moving quickly to deliver solutions for patients. Their hybrid work model fosters a sustainable work-life balance with unlimited vacation time, while regular "Home Weeks" bring employees together at the Boston headquarters to strengthen community and foster face-to-face engagement.

Pyxis Oncology is committed to fostering a diverse and inclusive workplace, believing that a variety of perspectives and backgrounds are crucial for success. Their hybrid work model allows for geographic flexibility, attracting talent from various locations and fostering a welcoming environment for all. They also prioritize inclusivity in their company culture, emphasizing values like "Diversity is our catalyst" and encouraging their employees to "Be You."